Keyword → healthcare

Medtronic Posts Strongest Revenue Growth in Ten Quarters, Reiterates Full-Year Outlook

Medtronic reported third-quarter fiscal 2026 revenue of $9.02 billion, an 8.7% year-over-year increase representing the company's highest enterprise revenue growth in ten quarters, beating analyst estimates of $8.89 billion. Non-GAAP diluted EPS of $1.36 beat consensus by three cents, and the medical device giant reiterated full-year organic revenue growth guidance of approximately 5.5% despite a projected $185 million tariff headwind.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.

London’s FTSE 100 Index Declines on Sector Weakness Despite Broader Risk Appetite

The FTSE 100 index fell 0.4% on January 28, 2026, pressured by declines in healthcare and banking stocks, offset partially by gains in the FTSE 250 and energy sectors. Pharmaceutical giants and major lenders slid amid mixed earnings data and profit taking, while miners and energy companies found support. Market participants maintained focus on upcoming earnings and U.S. monetary policy developments influencing global sentiment.